Amer Samad, Chief Executive Officer, 10% Owner at NEUROONE MEDICAL TECHNOLOGIES Corp (OSOK), bought 15,728 shares at $0.03 ($472) on 2017-05-19, disclosed to the SEC on 2017-07-14.
Open-market purchase of $472 OSOK by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.